Nomura Taichi, Niino Masaaki, Odani Toshio, Naganuma Ryoji, Amino Itaru, Miyazaki Yusei, Akimoto Sachiko, Tanei Zen-Ichi, Kimura Taichi, Minami Naoya, Kikuchi Seiji
Department of Neurology, National Hospital Organization Hokkaido Medical Center, Japan.
Department of Clinical Research, National Hospital Organization Hokkaido Medical Center, Japan.
Intern Med. 2025 Mar 15;64(6):941-945. doi: 10.2169/internalmedicine.3757-24. Epub 2024 Aug 28.
Macrophage activation syndrome (MAS) involves an excessive amount of acute inflammatory responses to inflammatory cytokines, particularly interleukin-6 (IL-6). IL-6 is also strongly associated with the pathophysiology of certain neuroimmunological diseases. However, there have so far been few reports of MAS being accompanied by neuroimmunological diseases. We herein report two cases of MAS comorbid with myasthenia gravis or neuromyelitis optica spectrum disorders, IL-6 related neuroimmunological diseases. Standard immunosuppressive therapies could not stabilize the symptoms in our cases until antibodies against the IL-6 receptor were administered. This finding suggests that it is important to consider the underlying pathophysiology of MAS in relation to these neuroimmunological diseases when treating affected patients.
巨噬细胞活化综合征(MAS)涉及对炎性细胞因子,特别是白细胞介素-6(IL-6)的过度急性炎症反应。IL-6也与某些神经免疫性疾病的病理生理学密切相关。然而,迄今为止,很少有关于MAS伴有神经免疫性疾病的报道。我们在此报告两例MAS合并重症肌无力或视神经脊髓炎谱系障碍,这两种均为与IL-6相关的神经免疫性疾病。在我们的病例中,标准免疫抑制疗法无法稳定症状,直到给予抗IL-6受体抗体。这一发现表明,在治疗受影响患者时,考虑MAS与这些神经免疫性疾病相关的潜在病理生理学非常重要。